2017
DOI: 10.1172/jci.insight.90656
|View full text |Cite
|
Sign up to set email alerts
|

Alterations in sarcomere function modify the hyperplastic to hypertrophic transition phase of mammalian cardiomyocyte development

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
11
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 55 publications
(63 reference statements)
1
11
1
Order By: Relevance
“…has recently been shown to be increased in angiotensin II-induced cardiac hypertrophy (Zhou et al, 2017), suggesting the pathophysiological role of cardiac formins in the development of cardiac hypertrophy. By contrast, we were not able to detect any upregulation of Fhod1 in heart tissues from Mybpc3-null mice, a model for cardiomyopathy (Harris et al, 2002;McConnell et al, 1999;Nixon et al, 2017). Although it is still possible that Fhod1 is upregulated in other types of pathological conditions and contributes to the pathogenesis via regulating actin organization in the sarcomere, the role of Fhod1 in the normal heart seems to be of minor relevance in the cardiac function.…”
Section: Discussioncontrasting
confidence: 68%
See 3 more Smart Citations
“…has recently been shown to be increased in angiotensin II-induced cardiac hypertrophy (Zhou et al, 2017), suggesting the pathophysiological role of cardiac formins in the development of cardiac hypertrophy. By contrast, we were not able to detect any upregulation of Fhod1 in heart tissues from Mybpc3-null mice, a model for cardiomyopathy (Harris et al, 2002;McConnell et al, 1999;Nixon et al, 2017). Although it is still possible that Fhod1 is upregulated in other types of pathological conditions and contributes to the pathogenesis via regulating actin organization in the sarcomere, the role of Fhod1 in the normal heart seems to be of minor relevance in the cardiac function.…”
Section: Discussioncontrasting
confidence: 68%
“…To estimate the effect of Fhod1 deletion on stress signaling in the heart, we performed quantitative real‐time PCR analysis of cardiac remodeling‐associated fetal genes that encode atrial natriuretic factor (ANF), B‐type natriuretic peptide (BNP), and β‐myosin heavy chain (β‐MHC; Figure d). Cardiac mRNA expression of these three genes in Fhod1 ‐null mice were comparable to that in control mice, whereas a significant increase was observed in Mybpc3 ‐null mice, which display a phenotype of cardiomyopathy (Harris et al, ; Matsuyama et al, ; Nixon et al, ). We further examined the effect of Fhod1 deletion on cardiac function by echocardiography, and found that there is no difference between Fhod1 ‐null and control mice (Table ).…”
Section: Resultsmentioning
confidence: 93%
See 2 more Smart Citations
“…Inhibition of myosin‐binding protein C (Mybpc3), a structural protein of the sarcomere that regulates myofilament stiffness and rigidity , reduces sarcomere density , leading to cardiac hypertrophy. Of interest, in heterozygous Mybpc3 +/− mice, the hypertrophic phenotype is mainly due to increase in CM cell size, however in homozygous Mybpc3 −/− animals this occurs mainly due to increased CM proliferation . The cardiac cytoskeleton in homozygous Mybpc3 knockout hearts contains less rigid sarcomeres and has decreased myofibrillar density.…”
Section: Remodelling Of the Sarcomeric Cytoskeleton During Cardiomyocmentioning
confidence: 99%